Pfiz­er starts re­open­ing of tor­na­do-dam­aged Rocky Mount plant, eyes Q4 for full op­er­a­tions

Pfiz­er has be­gun to re­open its tor­na­do-im­pact­ed fa­cil­i­ty in Rocky Mount, with the com­pa­ny fore­cast­ing it would be ful­ly op­er­a­tional by the fourth quar­ter.

On Ju­ly 19, Pfiz­er halt­ed pro­duc­tion and man­u­fac­tur­ing in its 1.4 mil­lion-square-foot fa­cil­i­ty in North Car­oli­na as it was hit by an EF-3 tor­na­do, pri­mar­i­ly dam­ag­ing the site ware­house.

Be­cause the site man­u­fac­tures near­ly a quar­ter of ster­ile in­jecta­bles used in US hos­pi­tals, there were con­cerns over short­ages. Pfiz­er sub­se­quent­ly placed a dozen prod­ucts on emer­gency or­der to ac­com­mo­date dis­tri­b­u­tion is­sues.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.